These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Deflazacort--an alternative to prednisolone? Drug Ther Bull; 1999 Aug; 37(8):57-8. PubMed ID: 10696685 [TBL] [Abstract][Full Text] [Related]
3. A longterm prospective study of the equipotency between deflazacort and prednisolone in the treatment of patients with polymyalgia rheumatica. Krogsgaard MR; Lund B; Johnsson B J Rheumatol; 1995 Sep; 22(9):1660-2. PubMed ID: 8523341 [TBL] [Abstract][Full Text] [Related]
4. Effects of prednisone and deflazacort on vertebral bone mass. Gennari C; Imbimbo B Calcif Tissue Int; 1985 Dec; 37(6):592-3. PubMed ID: 3937579 [TBL] [Abstract][Full Text] [Related]
5. [Glucocorticoids and risk of osteoporosis. On the problem of equivalent dose of desirable and undesirable effects of various glucocorticoids, exemplified by deflazacort]. Rotenberger J; Köbberling J Med Klin (Munich); 1993 Jul; 88(7):432-7. PubMed ID: 8377721 [No Abstract] [Full Text] [Related]
7. Mononuclear cells in corticosteroid-resistant asthma. Lane SJ; Lee TH Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 2):S49-51; discussion S52. PubMed ID: 8756788 [No Abstract] [Full Text] [Related]
8. Differential binding in vitro to glucocorticoid receptors of deflazacort and prednisolone. Luzzani F; Glässer A Eur J Pharmacol; 1981 Dec; 76(4):427-30. PubMed ID: 7327211 [TBL] [Abstract][Full Text] [Related]
9. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Keatings VM; Jatakanon A; Worsdell YM; Barnes PJ Am J Respir Crit Care Med; 1997 Feb; 155(2):542-8. PubMed ID: 9032192 [TBL] [Abstract][Full Text] [Related]
10. Comment on the study of deflazacort versus prednisone in the treatment of chronic inflammatory disorders. Messina OD; Barreira JC Arthritis Rheum; 1992 Jul; 35(7):841-2. PubMed ID: 1622425 [No Abstract] [Full Text] [Related]
11. The new steroids: clinical experience in ulcerative colitis. Jewell DP Mt Sinai J Med; 1990 Oct; 57(5):293-6. PubMed ID: 1710774 [No Abstract] [Full Text] [Related]
12. The molecular complexity of glucocorticoid actions in inflammation - a four-ring circus. Goulding NJ Curr Opin Pharmacol; 2004 Dec; 4(6):629-36. PubMed ID: 15525555 [TBL] [Abstract][Full Text] [Related]
13. Changes in bone mass during low dose corticosteroid treatment in patients with polymyalgia rheumatica: a double blind, prospective comparison between prednisolone and deflazacort. Krogsgaard MR; Thamsborg G; Lund B Ann Rheum Dis; 1996 Feb; 55(2):143-6. PubMed ID: 8712867 [TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis. Tuckermann JP; Kleiman A; McPherson KG; Reichardt HM Crit Rev Clin Lab Sci; 2005; 42(1):71-104. PubMed ID: 15697171 [TBL] [Abstract][Full Text] [Related]